BlackRock Amends Cassava Sciences Stake as of Dec 31, 2023
Ticker: FLNA · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1069530
| Field | Detail |
|---|---|
| Company | Cassava Sciences INC (FLNA) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its Cassava Sciences stake, signaling its latest position in the pharma stock.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 26, 2024, disclosing its ownership of Common Stock in Cassava Sciences Inc. as of December 31, 2023. This amendment, number 3, indicates a change in BlackRock's beneficial ownership, which is significant because BlackRock is a major institutional investor. For current or prospective shareholders of Cassava Sciences, this filing provides transparency into a large institutional holder's position, potentially influencing market sentiment and indicating BlackRock's ongoing investment strategy in the pharmaceutical company.
Why It Matters
This filing shows BlackRock's updated stake in Cassava Sciences, offering insight into a major institutional investor's confidence (or lack thereof) in the company's future. It can influence how other investors perceive the stock.
Risk Assessment
Risk Level: low — This is a routine disclosure of institutional ownership, not indicating any immediate financial distress or major corporate action.
Analyst Insight
Investors should note BlackRock's continued presence as a holder, but this filing alone doesn't provide enough detail (like percentage owned) to make a definitive investment decision. Further investigation into BlackRock's specific ownership percentage and Cassava Sciences' fundamentals is warranted.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Cassava Sciences Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- BlackRock will continue to hold a significant stake in Cassava Sciences Inc. for the foreseeable future. (BlackRock Inc.) — medium confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., a major institutional investment manager.
What company's securities are the subject of this filing?
The subject company is Cassava Sciences Inc., identified by the CUSIP Number 14817C107 and the name 'CASSAVA SCIENCES INC'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding CASSAVA SCIENCES INC (FLNA).